Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.34 USD | -3.23% | +7.67% | -82.49% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
157M | - | - | - | - | - | |
116B | ||||||
106B | ||||||
23.89B | - | |||||
21.58B | - | |||||
18.96B |